SE0202702D0 - Immunoassays for specific determination of SCCA isoforms - Google Patents

Immunoassays for specific determination of SCCA isoforms

Info

Publication number
SE0202702D0
SE0202702D0 SE0202702A SE0202702A SE0202702D0 SE 0202702 D0 SE0202702 D0 SE 0202702D0 SE 0202702 A SE0202702 A SE 0202702A SE 0202702 A SE0202702 A SE 0202702A SE 0202702 D0 SE0202702 D0 SE 0202702D0
Authority
SE
Sweden
Prior art keywords
immunoassays
scca
specific determination
well
isoforms
Prior art date
Application number
SE0202702A
Other languages
English (en)
Other versions
SE0202702L (sv
Inventor
Eva Roejer
Original Assignee
Canag Diagnostics Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canag Diagnostics Ab filed Critical Canag Diagnostics Ab
Priority to SE0202702A priority Critical patent/SE0202702L/sv
Publication of SE0202702D0 publication Critical patent/SE0202702D0/sv
Priority to AT03795518T priority patent/ATE532796T1/de
Priority to AU2003256194A priority patent/AU2003256194B9/en
Priority to CNA038235161A priority patent/CN1684981A/zh
Priority to CA2498524A priority patent/CA2498524C/en
Priority to EP03795518A priority patent/EP1539817B1/en
Priority to DK03795518.4T priority patent/DK1539817T3/da
Priority to PCT/SE2003/001332 priority patent/WO2004024767A1/en
Priority to KR1020057004488A priority patent/KR20050071493A/ko
Priority to HK06100144.9A priority patent/HK1080091A1/zh
Priority to JP2004535315A priority patent/JP2006516114A/ja
Priority to RU2005110410/13A priority patent/RU2005110410A/ru
Priority to BR0314207-8A priority patent/BR0314207A/pt
Priority to ES03795518T priority patent/ES2376167T3/es
Priority to US10/652,705 priority patent/US20040176577A1/en
Publication of SE0202702L publication Critical patent/SE0202702L/sv
Priority to US11/765,725 priority patent/US20080057520A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007Carcino-embryonic Antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • G01N33/575
    • G01N33/5758

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE0202702A 2002-09-10 2002-09-10 Immunotest för specifik bestämning av SCCA isoformer SE0202702L (sv)

Priority Applications (16)

Application Number Priority Date Filing Date Title
SE0202702A SE0202702L (sv) 2002-09-10 2002-09-10 Immunotest för specifik bestämning av SCCA isoformer
ES03795518T ES2376167T3 (es) 2002-09-10 2003-08-27 Inmunoensayos para la determinación espec�?fica de isoformas de scca.
DK03795518.4T DK1539817T3 (da) 2002-09-10 2003-08-27 Immunoassays til specifik bestemmelse af SCCA-isoformer
KR1020057004488A KR20050071493A (ko) 2002-09-10 2003-08-27 Scca 동소체의 특이적 결정을 위한 면역검사
CNA038235161A CN1684981A (zh) 2002-09-10 2003-08-27 用于单独测定scca同形异构体的免疫测定法
CA2498524A CA2498524C (en) 2002-09-10 2003-08-27 Immunoassays for specific determination of scca isoforms
EP03795518A EP1539817B1 (en) 2002-09-10 2003-08-27 Immunoassays for specific determination of scca isoforms
AT03795518T ATE532796T1 (de) 2002-09-10 2003-08-27 Immunassays zur spezifischen bestimmung von scca- isoformen
PCT/SE2003/001332 WO2004024767A1 (en) 2002-09-10 2003-08-27 Immunoassays for specific determination of scca isoforms
AU2003256194A AU2003256194B9 (en) 2002-09-10 2003-08-27 Immunoassays for specific determination of SCCA isoforms
HK06100144.9A HK1080091A1 (zh) 2002-09-10 2003-08-27 用於单独测定scca同形异构体的免疫测定法
JP2004535315A JP2006516114A (ja) 2002-09-10 2003-08-27 Sccaアイソフォームの特異的測定のためのイムノアッセー
RU2005110410/13A RU2005110410A (ru) 2002-09-10 2003-08-27 Иммуноанализы для специфического определения изоформ scca
BR0314207-8A BR0314207A (pt) 2002-09-10 2003-08-27 Imunoensaios para a determinação especìfica de isoformas de scca
US10/652,705 US20040176577A1 (en) 2002-09-10 2003-08-29 Immunoassays for specific determination of SCCA isoforms
US11/765,725 US20080057520A1 (en) 2002-09-10 2007-06-20 Immunoassays for specific determination of scca isoforms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0202702A SE0202702L (sv) 2002-09-10 2002-09-10 Immunotest för specifik bestämning av SCCA isoformer

Publications (2)

Publication Number Publication Date
SE0202702D0 true SE0202702D0 (sv) 2002-09-10
SE0202702L SE0202702L (sv) 2004-05-10

Family

ID=20288971

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0202702A SE0202702L (sv) 2002-09-10 2002-09-10 Immunotest för specifik bestämning av SCCA isoformer

Country Status (14)

Country Link
EP (1) EP1539817B1 (sv)
JP (1) JP2006516114A (sv)
KR (1) KR20050071493A (sv)
CN (1) CN1684981A (sv)
AT (1) ATE532796T1 (sv)
AU (1) AU2003256194B9 (sv)
BR (1) BR0314207A (sv)
CA (1) CA2498524C (sv)
DK (1) DK1539817T3 (sv)
ES (1) ES2376167T3 (sv)
HK (1) HK1080091A1 (sv)
RU (1) RU2005110410A (sv)
SE (1) SE0202702L (sv)
WO (1) WO2004024767A1 (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5750646B2 (ja) * 2009-12-07 2015-07-22 株式会社シノテスト Scca2濃度測定によるアレルギー疾患の検査方法
JP5750645B2 (ja) * 2009-12-07 2015-07-22 株式会社シノテスト アレルギー疾患の検査方法
CN102435740A (zh) * 2011-08-31 2012-05-02 内蒙古科慧生物科技有限责任公司 鳞状细胞癌抗原(scc)定量测定试剂盒及其检测方法
WO2013118073A1 (en) * 2012-02-07 2013-08-15 Bioalternatives Sas Serpinb4, as a marker for an early evaluation of the response to anti-egfr therapies by a non-invasive method
CN106318912B (zh) * 2016-08-23 2019-01-25 广州瑞博奥生物科技有限公司 杂交瘤细胞株scca1及其分泌的单克隆抗体和应用
CN109212190A (zh) * 2018-09-26 2019-01-15 郑州安图生物工程股份有限公司 一种检测鳞状细胞癌抗原的试剂盒
CN113125723A (zh) * 2019-12-31 2021-07-16 瑞博奥(广州)生物科技股份有限公司 一种检测男性恶性肿瘤标志物的检测芯片及其制备方法和应用
CN112280746A (zh) * 2020-10-29 2021-01-29 杭州华葵金配生物科技有限公司 一种细胞癌抗原杂交瘤细胞株及其单克隆抗体的应用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4668889A (en) * 1988-11-23 1990-06-12 The Administrators Of The Tulane Eductional Fund Monoclonal antibodies specific for tumor antigens
WO2001002603A1 (en) * 1999-06-30 2001-01-11 Jakob Stenman Diagnostic method for squamous cell carcinoma
SE521652C2 (sv) * 2001-03-15 2003-11-25 Canag Diagnostics Ab En skivepitelcellcancerrelaterad fusionsgen och motsvarande fusionsprotein

Also Published As

Publication number Publication date
CA2498524C (en) 2013-08-13
AU2003256194A1 (en) 2004-04-30
JP2006516114A (ja) 2006-06-22
HK1080091A1 (zh) 2006-04-21
KR20050071493A (ko) 2005-07-07
EP1539817A1 (en) 2005-06-15
AU2003256194B2 (en) 2010-10-07
RU2005110410A (ru) 2005-11-20
BR0314207A (pt) 2005-07-26
AU2003256194B9 (en) 2010-10-21
CN1684981A (zh) 2005-10-19
ATE532796T1 (de) 2011-11-15
ES2376167T3 (es) 2012-03-09
SE0202702L (sv) 2004-05-10
CA2498524A1 (en) 2004-03-25
DK1539817T3 (da) 2012-02-06
EP1539817B1 (en) 2011-11-09
WO2004024767A1 (en) 2004-03-25

Similar Documents

Publication Publication Date Title
EP0914155A4 (en) PROSTATE SPECIFIC MEMBRANE ANTIGEN MONOCLONAL ANTIBODIES
DE69936049D1 (de) Monoklonale antikörper spezifisch für die extrazelluläre domäne des prostata-spezifischen membranantigens
BRPI0410261B8 (pt) anticorpo monoclonal que se liga especificamente ao probnp, métodos para detecção específica de probnp in vitro e para diagnóstico de insuficiência cardíaca in vitro, kit para medição de probnp, e linhagem celular de hibridoma mab 1.21.3
PH12020551371A1 (en) Assays to detect neurodegeneration
DE60335022D1 (de) Internalisierende Antikörper spezifisch für das RAAG10 Zelloberflächenziel
DE60141844D1 (de) Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen
EP1381864A4 (en) DETECTION OF CANDIDA
TW200801202A (en) Alpha-enolase specific antibody and method of use
WO2005113000A3 (en) Anti-cancer activity of an anti-thymidine kinase monoclonal antibody
TW200741203A (en) Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody
WO2005120166A3 (en) Antibodies for selective apoptosis of cells
MX2022013738A (es) Ensayo de anticuerpos neutralizantes para proteinas terapeuticas.
SE0202702D0 (sv) Immunoassays for specific determination of SCCA isoforms
MX2008000282A (es) Anticuerpos monoclonales, lineas celulares de hibridomas, metodos y kits para la deteccion de fitasa.
BRPI0208021B8 (pt) genes de antígeno ii de carcinoma de células escamosas rearranjados
TW200622247A (en) Ileitis diagnostic assay
GB0616929D0 (en) Antibodies, assays and hybridomas
ATE378601T1 (de) Diagnostischer test für menschlisches matrix gla- protein und seine verwendung als biomarker
EP1591791A3 (en) Diagnostic assay for human matrix gla-protein and its use as a biomarker
WO2018226098A3 (en) METHODS OF TYPING NEUROLOGICAL DISORDERS AND CANCER, AND DEVICES THEREOF
SE0100595D0 (sv) Immunological detection of prostate diseases and prostatic-related diseases
WO2005114203A3 (en) Dominant b cell epitopes and methods of making and using thereof
WO2006060188A3 (en) Anti-tenascin monoclonal antibody immunoassays and diagnostic kits
IT1317355B1 (it) Anticorpi policlonali.
MX2025006813A (es) Anticuerpos anti-idiotipo cd70